Biopharmaceuticals: The Patent System and Incentives for Innovation

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Lipton, Alissa K.	en_US
dc.date.accessioned	2012-06-07T20:07:21Z
dc.date.issued	2004	en_US
dc.identifier.citation	Biopharmaceuticals: The Patent System and Incentives for Innovation (2004 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852103
dc.description.abstract	This paper discusses the requirements for patentability as applied to biotechnology and pharmaceutical inventions. Focusing on case law from the Court of Appeals for the Federal Circuit, as well as guidelines issued by the United States Patent and Trademark Office, the Paper describes the requirements of utility, novelty, nonobviousness, written description, and enablement. The Paper then goes on to summarize literature on the economics of patents and the structure of the biotechnology industry. The Paper argues that strong patent protection is vital in order to ensure innovation in the biotechnology industry. Finally, the Paper addresses issues in patenting recent developments in biotechnology.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	patentability	en
dc.title	Biopharmaceuticals: The Patent System and Incentives for Innovation	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T20:07:21Z